Relator Josephine Woytus, plaintiff in a personal injury action, instituted a proceeding in prohibition in the Missouri Court of Appeals, Eastern District, seeking to prohibit respondent trial judge, the Honorable Brendan Ryan, from compelling her to execute medical authorizations allowing defendants in the underlying suit to have
ex parte
discussions with relator’s treating physicians. The court of appeals issued a preliminary writ of prohibition. In making the writ absolute, the court of appeals (Smith, J. dissenting) distinguished but affirmed the general holding of
State ex rel. Stufflebam v. Appelquist,
Relator’s underlying suit for personal injuries arose out of an automobile accident on August 18, 1984. Defendants in the suit are Linda Mattingly, driver of the other vehicle in the accident (and an uninsured motorist at the time of the collision), and American Manufacturer’s Mutual Insurance Company, with whom relator had a liability insurance policy. Relator’s claim against the insurance carrier is based upon an allegation of uninsured motorist coverage under the policy.
Dr. M. Robert Hill and Dr. John Amot treated relator for the injuries she sustained in the accident. In response to defendant’s interrogatories, relator identified these doctors as treating physicians and, further, as expert witnesses who would testify at trial as “[djoctors who examined and treated me [and] will testify to the injuries I received in this collision.” Although defendants scheduled depositions of the doctors in March, 1988, depositions were not taken.
On April 1, 1988, defendants sought orders compelling plaintiff to authorize the doctors to discuss relator’s physical and mental condition privately with defendants. The motions sought orders under the authority of
Stufflebam v. Appelquist.
Respondent denied the motions as phrased but granted defendants leave to file amended motions praying that the trial court compel relator to execute authorizations allowing the doctors to speak privately to defendants’ attorneys. Defendants filed amended motions after which respondent ordered relator to execute medical authorizations to permit private discussions “as per Exhibit 8 contained at
I hereby authorize you to furnish and discuss with Coffelt & Coffelt, P.C., any and all information and records you have *391 concerning treatment rendered to me for one or all of the following injuries:
[parts of body and claimed conditions described]
This medical authorization does not require you to engage in discussions with Coffelt & Coffelt, P.C.; however, it does permit such discussions if you so desire.
In response, relator instituted this proceeding in prohibition.
Respondent presents a number of arguments in support of his claim that ex parte discussion is permissible under the Rules and supported by public policy. Respondent’s arguments emphasize conservation of medical and legal resources.
Through adoption of Rule 56.01(f)(2) this Court has encouraged informal discovery and discovery at the least expensive level when such discovery is accomplished by the agreement of the parties. In the case now before the Court, however, the patient has objected to ex parte discussion. The question, then, is whether the trial court possesses authority to compel the patient to authorize ex parte discussion.
Prior to the nineteenth century, in preparation for trial, parties to a lawsuit employed nothing more than mere speculation regarding the adversary’s strategy.
See generally, State ex rel. Schlueter Mfg. Co. v. Beck,
From early in Missouri’s history, however, the statutory grant of various discovery devices, including the right to take depositions and the right to inspection of documents, superseded equitable discovery.
Schlueter,
Under current practice, the purposes of discovery are to eliminate concealment and surprise,
Combellick v. Rooks,
Determination of the limits of authorized discovery in the State of Missouri commences with Rule 56. Rule 56.01(a) provides in pertinent part:
(a) Discovery Methods. Parties may obtain discovery by one or more of the following methods: depositions upon oral examination or written questions; written interrogatories; production of documents of things or permission to enter upon land or other property, for inspec *392 tion and other purposes; physical and mental examinations; and requests for admission.
Rule 56.01(b) provides in pertinent part:
(b) Scope of Discovery. Unless otherwise limited by order of the Court in accordance with these Rules, the scope of discovery is as follows:
(1) In General. Parties may obtain discovery regarding any matter, not privileged, which is relevant to the subject matter involved in the pending action, whether it relates to the claim or defense of the party seeking discovery or to the claim or defense of any other party, including the existence, description, nature, custody, condition and location of any books, documents or other tangible things and the identity and location of persons having knowledge of any discoverable matter.
Rule 56.01(b)(4) provides in pertinent part:
(4) Trial Preparation: Experts. Discovery of facts known and opinions held by experts, otherwise discoverable under the provisions of subdivision (b)(1) of this Rule and acquired or developed in anticipation of litigation or for trial, may be obtained only as follows:
(a) A party may through interrogatories require any other party to identify each person whom the other party expects to call as an expert witness at trial and to state the general nature of the subject matter on which the expert is expected to testify.
(b) A party may discover by deposition the facts and opinions to which the expert is expected to testify.
Although, as respondent notes, the Rules do not expressly forbid ex parte discussion, neither do the Rules expressly authorize such discussion as a method of discovery. Rule 41.04 states that “[i]f no procedure is specially provided by rule, the court ... shall proceed in a manner consistent with the applicable statute, or statutes, if any, and precedent_” Although not precisely on point, Rule 41-04 guides the court’s analysis where the proposed procedure is not specially provided by rule.
The absence of explicit authority in the
Rules
leads necessarily in this case to a re-examination of the confidential and fiduciary relationship existing between a patient and the patient’s physician, for it is the potential burden and intrusiveness involved in the physician’s furnishing the information that is to be balanced against the need for and stated purposes of discovery.
See State ex rel. Anheuser v. Nolan,
In § 491.060, RSMo 1986, the legislature established a privileged relationship between physician and patient:
The following persons shall be incompetent to testify: ... (5) A physician or surgeon, concerning any information which he may have acquired from any patient while attending him in a professional character, and which information was necessary to enable him to prescribe for such patient as a physician, or do any act for him as a surgeon.
The purpose of the physician-patient privilege is to enable the patient to secure complete and appropriate medical treatment by encouraging candid communication between patient and physician, free from fear of the possible embarrassment and invasion of privacy engendered by an unauthorized disclosure of information.
See, e.g., Petrillo v. Syntex Laboratories, Inc.,
The public policy evidenced by the statutory privilege is also reflected in the code of ethics and professional conduct to which physicians must adhere to gain and retain medical licensure in the State of Missouri. See § 334.100.2, RSMo 1986. The code of ethics for the medical profession includes the Hippocratic Oath, the purpose of which is to promote full disclosure. Similarly, as the Stufflebam court recognized, Principle *393 IV of the American Medical Association’s Principles of Medical Ethics states:
A physician shall respect the rights of patients, of colleagues, and of other health professionals, and shall safeguard patient confidences within the constraints of the law.
Finally, § 5.05 of the Current Opinions of the Judicial Council of the American Medical Association (1984) states:
The information disclosed to a physician during the course of the relationship between physician and patient is confidential to the greatest possible de-gree_ The physician should not reveal confidential communications or information without the express consent of the patient, unless required to do so by law.
Stufflebam,
The physician-patient privilege, however, is not absolute. Under certain circumstances, the protection afforded by the privilege must give way to society’s interest in ascertaining the truth. In
McNutt v. Keet,
After
McNutt,
however, this Court continued strongly to affirm the importance of the underlying confidential and fiduciary relationship of physician and patient. In
State ex rel. McCloud v. Seier,
Whether the Rules permit a court to enlarge the constructive waiver of the privilege turns on the question of the balance to be struck between the interest in preserving the physician-patient confidential and fiduciary relationship and the interest in achieving the purposes of discovery.
Jurisdictions that have addressed the issue are divided as to the appropriate answer. Numerous jurisdictions have held that the burden placed on defendants by having to use formal discovery as specially authorized under the
Rules
is outweighed by society’s interest in preserving the underlying confidential and fiduciary relationship between physician and patient.
See Loudon v. Mhyre,
In addition to the Missouri Court of Appeals, Southern District, holding in
Stuffle-bam,
a number of other courts have approved
ex parte
contact.
See Doe v. Eli Lilly & Co., Inc.,
Respondent argues that
ex parte
discussion is not expressly prohibited by the
Rules.
As the previous discussion demonstrates, however, the mere silence of the
Rules
is not determinative. A public policy assessment is required to resolve the question.
See Petrillo,
Respondent also contends that ex parte discussion not only furthers the search for the truth but also leads to the conservation of both medical and legal resources. Respondent submits that ex parte discussion is an efficient and cost-effective way to eliminate nonessential witnesses and encourages the early evaluation and settlement of cases and a corresponding conservation of resources. Respondent further argues that ex parte discussion requires less preparation than formal discovery methods, is easier to schedule, is less time consuming, and allows for a “spontaneity and candor” that is not available under the formal discovery methods.
It is not clear that ex parte discussion ultimately results in the conservation of resources. The defendant must expend time and effort to prepare the authorization and move for the court order compelling execution. The defendant will spend further time and effort to secure and review the plaintiff’s medical records so that the defendant has an intelligent basis upon which to have an ex parte discussion with the physician. Simultaneously, the plaintiff must respond to the motions and orders and brief the physician on the limits of permissible disclosure. The physician, in turn, must cull the patient’s records, confer with the patient’s attorney, and then confer with the defendant’s attorney. It is likely that the physician will later be questioned by the plaintiff’s attorney about the discussion. Notwithstanding this time and effort, defendant still may deem it prudent to depose the physician.
As for early evaluation and settlement of a case, it is the information obtained, rather than the
ex parte
discussion itself, that leads to resolution.
Petrillo,
Because the information that may be secured legitimately through
ex parte
discussion may otherwise be obtained, the potential harm to the physician-patient relationship inherent in
ex parte
discussion between the defendant and the plaintiff’s treating physician assumes greater relevance.
Petrillo,
In addition, ex parte discussion creates an opportunity for the consideration of extrinsic matters that may subtly compromise a physician’s duty of loyalty to the patient:
This court will not overlook the current concerns in the medical malpractice insurance industry and the attitudes of physicians and carriers alike. An unauthorized ex parte interview could disintegrate into a discussion of the impact of a jury’s award upon a physician’s professional reputation, the rising cost of malpractice insurance premiums, the notion that the treating physician might be the next person to be sued, and other topics which might influence the treating physician’s views. The potential for impropriety grows even larger when defense counsel represents the treating physician’s own insurance carrier and when the doctor, who typically is not represented by his personal counsel at the meeting, is unaware that he may become subject to suit by revealing the plaintiff/patient’s confidences which are not pertinent to the pending litigation.
Manion v. N.P.W. Medical Center of N.E. Pa., Inc.,
Respondent’s policy arguments are not without merit. In balancing the interests involved, however, this Court will not require that a non-enumerated discovery method be added to those already available under the Rules. Information or evidence that can be obtained legitimately through ex parte discussion can also be obtained through the methods of discovery listed in the Rules. Any burdens caused defendants by being restricted to the specially enumerated discovery procedures are outweighed by the potential risks to the physician-patient relationship in deviating from those procedures.
The trial court entered an order requiring relator to execute medical authorizations allowing the defendants to have ex parte discussion with relator’s treating physicians. This Court holds that respondent lacked authority under the Rules to make such an order. To the extent that Stufflebam sanctioned court authorized ex parte discussion under the Rules, it is abrogated.
The preliminary writ of prohibition is made absolute.
Notes
. Even the courts which have permitted
ex parte
interviews recognize that a doctor cannot be required to submit to the interview.
See Alston,
